Cilostazol 50mg Tablets (Cilostazol)

Adult dose

As cilostazol, typically, adults take 100mg orally twice a day. The dosage may be adjusted according to age and symptoms.

This medication may increase the heart rate, potentially resulting in angina symptoms, so caution should be exercised for any angina symptoms such as chest pain. It should not be administered to patients at risk of bleeding or those with bleeding disorders, and it is also unsafe to use in patients with a recent history of hemorrhagic stroke or surgery. Patients with congestive heart failure may experience worsening symptoms when taking this medication and should avoid it. Patients who have had allergic reactions to this drug or its components should not use it, and pregnant women, women who may become pregnant, or nursing mothers should also avoid it. Patients taking anticoagulants, antiplatelet agents, thrombolytics, and other drugs that increase the risk of bleeding should be cautious when using this medication as the risk of bleeding may increase. Women who are menstruating should use this medication cautiously due to the increased risk of bleeding. Patients with coronary artery stenosis should be cautious as this medication may increase heart rate and provoke angina. Patients with severely impaired kidney function or moderate to severe liver dysfunction may have increased blood concentration of this medication, requiring careful administration. Diabetic patients or those with poorly controlled blood sugar may be at higher risk for bleeding side effects and should be cautious. Patients with hypertension that continuously increases should monitor blood pressure control when taking this medication. Patients with cardiac arrhythmias or structural heart abnormalities may experience cardiac-related symptoms during this medication and should be closely observed. During the use of this medication, if serious adverse symptoms such as bleeding, headache, vomiting, or difficulty breathing occur, immediate medical consultation is necessary, and administration should be discontinued. Dizziness or drowsiness may occur, so caution is required when driving or operating machinery. This medication is metabolized in the liver, so when taken with certain medications, blood concentration may change, necessitating dosage adjustments or co-administration caution. Pregnant or nursing women should not take this medication as it may affect the fetus or baby. Safety for children and infants has not been established, and caution is needed for use. Elderly patients may have decreased bodily functions, so they should receive reduced dosages or careful administration of this medication.

Serious side effects

Hives, severe swelling (edema), severe allergic reactions, bleeding tendencies (cerebral hemorrhage, intracranial hemorrhage, pulmonary hemorrhage, gastrointestinal bleeding, nasal bleeding, retinal hemorrhage, hematuria), liver abnormalities (jaundice, elevated AST/ALT), interstitial pneumonia (fever, cough, difficulty breathing, chest X-ray abnormalities, eosinophilia), congestive heart failure, myocardial infarction, angina, ventricular tachycardia, palpitations, increased blood pressure, severe edema, abnormal heart rate, severe neurological symptoms (headache

Mild side effects

• Headache
• nausea
• vomiting
• diarrhea
• insomnia
• dizziness
• loss of appetite
• abdominal pain
• skin rash
• itching

This medication should be stored in a tightly sealed container to prevent air and moisture from entering. It should be kept at room temperature between 1 and 30 degrees Celsius. This helps to maintain the effectiveness and safety of the medication.

Appearance

White round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle